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Background: Enterococci are the most important multidrug resistant organisms associated with
immunocompromised patients. Data are lacking about the epidemiology of vancomycin resistant Enterococci (VRE)
in Ethiopia. This study aimed to assess the prevalence of VRE, their susceptibility patterns to different antibiotics and
associated risk factors in fecal samples of Human Immunodeficiency Virus (HIV) positive and HIV negative clients.
Methods: A cross sectional study was carried out in a total of 226 (113 HIV positive and 113 HIV negative) clients,
from July 1/2013 to September 30/2013 at the University of Gondar Teaching Hospital. Data on socio-demographic
characteristics and risk factors were collected with a short interview guided by pre-tested structured questionnaire.
The enterococci were isolated and identified from stool sample using standard bacteriological procedures. Kary
Bauer disk diffusion method was used to determine the susceptibility patterns of Enterococci isolates. Data were
entered and analyzed using SPSS version 20 statistical package.
Results: The overall colonization of Enterococci was 88.9% (201/226) of which 11 (5.5%) were VRE. The prevalence of
VRE among clients with and without HIV infections were 8(7.8%) and 3(3.1%), respectively. Ninety percent of the
Enterococci isolates (181/201) were resistant to two or more antibiotics tested. Isolates of Enterococci recovered from
stool samples of HIV infected patients were more resistant to amoxicillin and amoxicillin-calvulinic acid than HIV
negative clients (P < 0.05). Antibiotic treatment for the last 2 weeks was found to be the risk factor that showed
statistically significant association with the presence of high VRE colonization. However, the socio-demographic
variables and factors such as malnutrition, leucopenia, thromobocytopenia, anaemia, duration of Highly Active
Antiretroviral Therapy, CD4 cell count, stage of WHO and drinking alcohol were not associated with VRE (P > 0.05).
Conclusion: The high prevalence of VRE in this study signals the emergence of VRE in the study area. Prior
antibiotic treatment was associated with VRE colonization. Therefore, rational use of antibiotics and more detailed
study using phenotypic and genotypic methods are needed.
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Enterococci are normal inhabitants of the gastrointestinal
tract of humans and animals. Two species cause most
enterococcal infections, Enterococcus faecalis and E. fae-
cium. Enterococci cause urinary tract infections mainly
followed by intra-abdominal and pelvic infections. They
also cause surgical wound infections, bacteraemia, endo-
carditis, neonatal sepsis and rarely meningitis [1].
Among the risk factors, previous antibiotic treatment
[2], duration of hospitalization (≥7 days), and duration
of vancomycin use (≥7 days) [3], surgical units or
intensive-care units; co-morbidities such as diabetes,
renal failure; and the presence of a urinary catheter [4],
are among the many risk factors for colonization or in-
fection with vancomycin resistance Enterococci (VRE).
Critically ill patients or those with severe underlying
disease or immunosuppression such as persons who
have had an intra abdominal or cardio-thoracic surgical
procedure or an indwelling urinary or central venous
catheter are also important risk factors [5]. Moreover,
HIV-positive patients often receive antibiotic therapy
and have frequent contact with the healthcare system,
both of which are factors that have been associated with
an increased risk of infection with VRE in other popula-
tions [6].
The relative importance of Enterococcus as a pathogen
has increased with the occurrence of high-level resistance
to multiple antimicrobial drugs, such as ampicillin and
vancomycin [7]. The emergence of VRE has alarmed the
global infectious diseases community due to few option
left for disease management, resistance gene transfer from
Enterococci to Staphylococcus aureus and presence of dif-
ferent selection pressures for VRE proliferation and rapid
expansion of resistant populations [8]. The prevalence
of VRE was reported in Europe, Asia, Australia, South
America and some countries of Africa [9]. However, there
is no enough data available on the epidemiology and risk
factors of VRE in Ethiopia. The present study aimed to as-
sess the prevalence of VRE, their susceptibility patterns to
different antibiotics and associated risk factors in fecal
samples of HIV positive and HIV negative clients at the
University of Gondar Teaching Hospital.Methods
Study design, area and period
A cross sectional study was carried out from July 1/
2013 to September 30/2013 at the University of Gondar
Teaching Hospital. The hospital is located in Gondar
town, 737 km Northwest of Addis Ababa. It has 400
beds and provides health care referral services for over
5 million inhabitants in Northwest Ethiopia. The Uni-
versity Teaching hospital has ART clinic and blood bank
center.Study population
HIV positive patients attending ART clinic and HIV
negative blood donors at the University of Gondar
Teaching Hospital during the study period were enrolled
in this study.
Sample size and sampling technique
The sample size was determined by using EPI INFO
version 3.5.3 in double population proportion. Since
there is no previous study done in this area, 50% preva-
lence was used for HIV negative clients. HIV positive
patients are assumed to have 20% more VRE carriage
than HIV negative clients, 70%. Considering the two
prevalence, power 80% at 95% confidence with 1:1 ratio
the final sample size was 226 (113 HIV infected patients
and 113 HIV negative blood donors). The last 3 years
hospital report showed that an average of 57 HIV posi-
tive clients was visited the ART laboratory daily. We
calculated the total participants in 3 months study
period (57 × 90 days = 5130). Since our sample size is
113 HIV positive patients we calculated the k = value to
be 45. The first one was selected with lottery method
from 1-45 cases. Then every 45th patients were included
in this study. Consecutive HIV negative volunteers
blood donors (n = 113) were also included in the study.
Data collection
Socio-demographic and clinical data and other possible
factors responsible for colonization of VRE such as anti-
microbial therapy, drinking alcohol and others were col-
lected using pre-tested structured questionnaire. Five
milliliters of blood was drawn from each client by an
experienced laboratory technologist. The HIV status of
the clients was determined using rapid test kit (KHB,
STAT pak and Uni-Gold) following the current Ethiop-
ian algorithm [10]. The CD4 count (for HIV positives)
and complete blood count were done using BD FACS
count and Sysmex Machine respectively.
Stool sample collection and processing
The clients were provided with wide-mouthed, sterile
plastic containers and informed to submit stool speci-
mens. The collected stool specimens were streaked on
Bile Esculin Azide agar (Hardy Diagnostics, Santa Maria,
CA, USA) and incubated for 24 hours at 37°C. Plates
were observed for appearance of characteristic colonies
of growth and blackening. Typical characteristic colonies
were selected randomly for characterization and pre-
sumptive identification of Enterococcci [11]. Each isolate
was also assessed using Gram staining, catalase test and
its growth in 6.5% NaCl broth. Presumptive pure col-
onies were picked and inoculated into Brain Heart Infu-
sion (BHI) broth, and incubated at 45°C for 24 hours
and growth in the medium was assessed by its turbidity.
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Enterococccus species [11].Antimicrobial susceptibility testing
Antimicrobial susceptibility testing for each isolate was
done using Muller-Hinton agar (OXOID, UK) disc diffu-
sion method [12]. Antimicrobial susceptibility patterns
of Enterococci were assessed against nine antibiotic discs
(all OXOID, UK). These were vancomycin 30 μg, ampicillin
10 μg, amoxicillin 10 μg, amoxicillin-clavulinic acid
10 μg, ciprofloxacin 5 μg, chloramphenicol 30 μg, erythro-
mycin 15 μg, gentamicin 10 μg and trimethoprim-
sulfamethoxazole 1.25/23.75 μg.Quality control
Reference strain of Staphylococcus aureus ATCC 25923
and E. faecalis ATCC 51299 were used as negative and
positive control, respectively.Table 1 Socio-demographic characteristics of clients with and



























Divorced 1 (0.9)Data analysis
Data were entered and analyzed using SPSS version 20.
Descriptive statistics were employed and odds ratio (OR)
was used to determine the strength of association. Multi-
variate analysis using logistic regression model was used
to analyze the association between VRE colonization and
potential risk factors. Those variables with over all P value
less than 0.2 in the bivariate analysis were entered into
multivariate analysis. P-values < 0.05 was considered statis-
tically significant.
Definitions: Leukocytosis and leucopenia were defined
as having WBC count greater than 12,000/mm3 and
less than 4,000/mm3, respectively. A client was named
as thrombocytopenic when she/he had a platelet count
of <100,000/ μL.Ethical consideration
The study was approved by the research and ethics
committee of the School of Biomedical and Laboratorywithout HIV at the University of Gondar Teaching
All (n = 226)
Positive (n = 113)
Number (%) Number (%)
53 (46.9) 123 (54.4)
60 (53.1) 103 (45.6)
36.12 ± 8.05 (23-65) 35.62 ± 9.54 (19-66)
0 (0) 7 (3.1)
35 (31.1) 74 (32.7)
53 (46.9) 96 (42.5)
21 (18.6) 36 (15.9)
3 (2.7) 9 (4.0)
1 (0.9) 4 (1.8)
31 (27.4) 52 (23.0)
82 (72.6) 174 (77.0)
110 (97.3) 213 (94.2)
3 (2.7) 13 (5.8)
23 (20.4) 69 (30.5)
51 (45.1) 115 (50.9)
14 (12.4) 16 (11.5)
25 (22.1) 26 (7.1)




Total Enterococci OR (95% CI) P-value
VRE VSE
Number (%) Number (%)
Positive 103(51.2) 8(7.8) 95(92.2) 2.67(0.62 – 13.12) 0.14
Negative 98(48.8) 3(3.1) 95(96.9) 1.00
Total 201(100) 11(5.5) 190(94.5)
VRE = Vancomycin resistant Enterococci; VSE = Vancomycin Sensitive Enterococci.
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sent was also obtained from each client.
Results
Socio-demographic characteristics of the clients
A total of 226 (113 HIV positive and113 HIV negative)
clients were included in this study. One hundred and
twenty three (54.4%) were males and 103 (45.6%) were
females. The mean age and standard deviation was
35.62 ± 9.54 ranged from 19-66 years. Majority of the cli-
ents were literate 174 (77.0%) and urban residents 213
(94.2%) (Table 1).
Prevalence of VRE among HIV positive and HIV negative
clients
Among 226 clients growth of Enterococcus species was
seen in 201 (88.9%) stool specimens. The colonization of
Enterococci among HIV positives and HIV negatives cli-
ents was 103 (91.2%) and 98 (86.7%), respectively. There
was no statistically significant difference in the isolation
frequency of Enterococci among clients with and without
HIV infection (P = 0.29).
Among the 201 isolates of Enterococci in this study, 11
(5.5%) were VRE. The prevalence of VRE among HIV
positive and HIV negative clients was 8 (7.8%) and
3 (3.1%), respectively. No significant association wasTable 3 Antimicrobial resistance patterns among clients with
Hospital, Northwest Ethiopia, 2013











MDR 91(92.8) 90(91.8observed between VRE and HIV sero-status (P = 0.14;
OR = 2.67; 95% CI = 0.62– 13.12) (Table 2).Antimicrobial susceptibility pattern of Enterococcci
One hundred eighty one (90%) isolates were resistant to
two or more antimicrobials tested. Among 201 Entero-
cocci isolates tested 113 (56.2%) were resistant to amoxi-
cillin. The amoxicillin resistance Enterococci were 65
(63.1%) and 48 (42.5%) among HIV positives and HIV
negative clients, respectively. Fifty five isolates (27.4%) of
Enterococci were resistant to amoxacillin-clavulinic acid,
of which, 35 (33.9%) and 20 (20.4%) were from HIV pos-
itives and HIV negatives, respectively. There was statisti-
cally significant difference of resistance to amoxicillin,
amoxacillin-clavulinic acid and erythromycine between
isolates from HIV positive and HIV negative clients (P <
0.05). However, no statistically significant differences
were observed in resistance pattern for the antibiotics:
ampicillin, chloroamphinicol, ciprofloxacillin, gentamy-
cine, sulphamethaxozole and vancomycin in HIV posi-
tives and HIV negative clients (P > 0.05) (Table 3).
All isolates of VRE were multidrug resistant and all
isolates of VRE in HIV positive patients were resist-
ant to Ampicillin, Amoxacillin and Gentamycin while
in HIV negative patients all isolates of VRE wereand without HIV at the University of Gondar Teaching
gative N = 98 Total N = 201 X2 P-value
r (%) Number (%)
) 160(79.6) 0.27 0.49
) 113(56.2) 4.07 0.04
) 55(27.4) 4.65 0.03
) 25(12.4) 0.01 0.94
) 68(33.8) 3.37 0.06
) 127(63.2) 4.29 0.07
) 144(71.6) 0.06 0.80
) 93(46.4) 0.57 0.45
11(5.5) 2.15 0.14
) 181(90) 0.68 0.41
Table 4 VRE (n = 11) isolates resistant patterns among clients with and without HIV at the University of Gondar
Teaching Hospital, Northwest Ethiopia, 2013
Resistant to antibiotics HIV positive N = 8 HIV Negative N = 3 Total N = 11
Number (%) Number (%) Number (%)
Ampicillin 8 (100) 3 (100) 11 (100)
Amoxacillin 8 (100) 1 (33.3) 9 (81.8)
Amoxacillin-clavulinic acid 5 (62.5) 1 (33.3) 6 (54.5)
Chloroamphinicol 3 (37.5) 2 (66.7) 5 (45.5)
Ciprofloxacillin 2 (25) 2 (66.7) 4 (36.4)
Erythromycin 7 (87.5) 3 (100) 10 (90.9)
Gentamycin 8 (100) 2 (66.7) 10 (90.9)
Trimethoprim-sulfamethoxazole 4 (50) 3 (100) 7 (63.6)
MDR 8 (100) 3 (100) 11 (100)
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sulfamethoxazole (Table 4).
Associated risk factors with VRE
Majority of VRE was isolated from females, age > 31 years
and urban residents. No significant association betweenTable 5 Socio-demographic characterstics and prevalence of




VRE (n = 11)
HIV positive HIV n
No. (%) No. (%
Sex
Male 3 (60.0) 2 (40.0
Female 5 (83.3) 1 (16.7
Age (years)
11-20 0 (0) 0 (0)
21-30 2 (100) 0 (0)
31-40 4 (80.0) 1 (20.0
41-50 2 (50.0) 2 (50.0
51-60 0 (0) 0 (0)
61+ 0 (0) 0 (0)
Education status
Illiterate 1 (33.3) 2 (66.7
Literate 7 (87.5) 1 (12.5
Residence
Urban 7 (70.0) 3 (30.0
Rural 1 (100) 0 (0)
Marital status
Single 1 (100) 0 (0)
Married 4 (57.1) 3 (42.9
Widowed 2 (100) 0 (0)
Divorced 1 (100) 0 (0)
Over all 8 (72.7) 3 (27VRE and socio-demographic characteristics such as,
age, sex, educational status, marital status and residence
(P > 0.05) (Table 5).
Prevalence of VRE was significantly associated with
antibiotic treatment more than 2 weeks (P = 0.01; AOR =







) 0.54 3.33 (0.12-156)
NA NA
— 1.00
) 0.71 0.00 (0-76.65)
) 0.40 0.00 (0-14.83)
NA NA
NA NA





) 0.62 0.00 (0-40.29)
NA NA
NA NA
.3) 0.14 2.67 (0.62-13.12)
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count, WBC counts, platelet counts, nutritional status,
WHO stage, drinking alcohol habit and anemic status




Number (%) Number (
Antibiotic treatment (>2 weeks)
Yes 10 (9.6) 94 (90.4)
No 1 (1.0) 96 (99.0)
CD4
*
≤350 5 (11.4) 39 (88.6)
>350 3 (5.1) 56 (94.9)
HAART
Yes* 8 (7.8) 94 (92.2)
No 3 (3.0) 96 (97.0)
HAART Duration (Year)*
≤2 2 (6.7) 28 (93.3)
>2 6 (8.2) 67 (91.8)
WBC counts
Normal 11 (6.6) 156 (93.4)
Leucopenic 0 (0) 27 (100)
Leucocytosis 0 (0) 7 (100)
Platelet
Normal 10 (5.6) 168 (94.4)
Thrombocytopenic 0 (0) 12 (100)
Thrombocytosis 1 (9.1) 10 (90.9)
Nutritional status
Normal 8 (4.7) 161 (95.3)
Malnourished 2 (13.3) 13 (86.7)
Overweight 1 (5.9) 16 (94.1)
Anemic
Yes 11 (5.8) 179 (94.2)
No 0 (0) 11 (100)
Drinking alcohol
Yes 2 (3.4) 57 (96.6)
No 9 (6.3) 133 (93.7)
WHO stage*
I 2 (8.3) 22 (91.7)
II 0 (0) 15 (100)
III 2 (6.7) 28 (93.3)
IV 4 (11.8) 30 (88.2)
*Only for HIV infected patients.Discussion
In the present study the overall prevalence of Enterococci
was 201/226(88.9%). This was consistent with the previ-




P-value AOR (95% CI)
%)
104 (51.7) 0.01 10.21 (1.31 – 217.40)
97 (48.3) — 1.00
44 (42.7) 0.21 2.39 (0.46 – 13.57)
59 (57.3) — 1.00
102 (50.7) 0.13 2.72 (0.63 – 13.40)
99 (49.3) — 1.00
30 (29.1) — 1.00
73 (70.9) 0.57 1.25 (0.21 – 9.62)
167 (83.1) — 1.00
27 (13.4) 0.18 0.00 (0.00 – 2.92)
7 (3.5) 0.62 0.00 (0.00 – 12.95)
188 (88.6) — 1.00
12 (6.0) 0.51 0.00 (0.00 – 8.40)
11 (5.4) 0.49 1.68 (NA)
169 (84.1) — 1.00
15 (7.5) 0.19 3.10 (0.41 – 18.57)
17 (8.5) 0.59 1.26 (NA)
190 (94.5) 0.52 UD
11 (5.5) — 1.00
59 (29.4) 0.32 0.52 (0.07 – 2.69)
142 (70.6) — 1.00
24 (23.3) — 1.00
15 (14.6) 0.37 0.00 (0.00 – 6.91)
30 (29.1) 0.60 0.79 (0.07 – 8.68)
34 (33.3) 0.51 1.47
0.20 – 12.82)
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colonization might be due to the advanced molecular
method in the previous study.
The prevalence of Enterococci was higher in HIV posi-
tives (91.2%) than HIV negatives (86.7%) clients. How-
ever, this was not statistically significant (P = 0.14).This
result was in line with reports by Hijazi [15] in hospital-
ized patients (94%) and in individuals living in the com-
munity (89%).
The prevalence of VRE in this study was 11/201(5.5%).
This was consistent with reports from Korea, 4.5% [16]
and lower than reports from Egypt (25%) isolated from
pediatric patients [17] and health care workers in inten-
sive care units (9.5%) [18]. These differences might be
due to the study design and study participants (pediatric
age and intensive care unit) in the previous study.
The prevalence of VRE among HIV positives (7.8%) in
the present study was higher than reports from USA, 0%
[19] and 4.7% [6]. This variation might be due to differ-
ence in the study population where most of the clients
in the present study had habit of animal contact and this
was supported by Bekele and Ashenafi, reported as 100%
VRE Enterococci isolated from faeces of chicken and cat-
tle in Ethiopia [20]. Comparison of colonization of VRE
among HIV positives (7.8%) and HIV negative (3.1%) cli-
ents’ revealed that there was a slightly higher VRE in
HIV positive patients. The higher VRE among HIV posi-
tives might be due to repeated exposure to different an-
tibiotics [6] and immune-suppression [21] which are
important risk factors for colonization or infection with
VRE.
Among risk factors studied for VRE, a patient with a
history of prior antibiotic use was found to be important
factor (P = 0.01). Similar reports from Iran showed that
antibiotic exposure can cause the emergence of VRE by
inducing the expression of resistance genes and by
selecting strains already expressing these genes and alter-
ing the competing microbial flora in the GI tract, thereby
increasing VRE concentration in the stools [22,23]. How-
ever, stool consistency, CD4+ count, HARRT, HARRT
duration (year),WBC and platelet count, nutritional
status, anaemia, drinking alcohol, WHO stage for HIV
were not statistically significant risk factors for VRE
(P > 0.05). This was consistent with previous study in
USA [6].
Among 201 isolates of Enterococci 181 (90%) were re-
sistant to two or more antibiotics tested. Similarly over
80% of multiple drug resistance (MDR) Enterococci iso-
lates were reported from cattle in Addis Ababa [20]. Al-
though high percentage of resistance against ampicillin
(79.6), gentamaycin (71.6) and erythromycin (63.2) were
observed, no significant difference was seen between
HIV positive and HIV negative clients. However, the re-
sistance pattern of Enterococcus isolates to amoxicillinand amoxicillin-clavulinic acid were significantly higher
in HIV positive than HIV negative clients. This signifi-
cant difference might be due to the frequent prescrip-
tion of broad spectrum antibiotic for HIV patients. The
high prevalence of MDR enterococccal colonization in
humans may lead to infection with reduced treatment
options.
Limitation of the study
The isolated enterococcci were not indentified to species
level.
Conclusion
The prevalence of VRE in clients attending the Univer-
sity of Gondar Hospital was 5.5%. Patients with prior ex-
posure to antibiotics for more than two weeks had
higher colonization than their respective group. The
presence of 11 (5.5%) prevalence of VRE in this study
signals the emergence of VRE in the study area. There-
fore, rational use of antibiotics and more detailed study
using phenotypic and genotypic methods are needed.
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